Printer Friendly

Trice Medical Names Hawkins to its Board of Directors.

M2 PHARMA-April 5, 2016-Trice Medical Names Hawkins to its Board of Directors

(C)2016 M2 COMMUNICATIONS

- US-based medical device company Trice Medical has appointed William Hawkins to the company's board of directors, effective 1 April 2016, the company said.

Hawkins' most recent position was with Immucor, Inc., where he served as its president and CEO from October 2011 to July 2015; currently, he is its Lead director.

Prior to joining Immucor, Hawkins served as chairman and CEO of Medtronic, one of the world's largest and most innovative medical technology companies. Hawkins' career spans more than three decades.

Before joining Medtronic, Hawkins was the CEO of Novoste, an Atlanta-based medical technology company.

Hawkins has a consistent track record of driving value-creating innovation that has revolutionized medical care and strengthened healthcare systems globally.

He has played a leadership role in Washington, DC on both healthcare policy and with matters involving the FDA.

Trice Medical was founded to fundamentally improve orthopedic diagnostics for the patient, physician, and payor by providing instant, eyes-on, answers.

The company has developed fully integrated camera-enabled technology, the mi-eye+, that provides a clinical solution optimized for the physician's office.

((Comments on this story may be sent to info@m2.com))

COPYRIGHT 2016 Normans Media Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2016 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:M2 Pharma
Date:Apr 5, 2016
Words:201
Previous Article:NeoChord Names Martin to its Board of Directors.
Next Article:Medical Device Maker Zyga Technology Enrolls First Patients in Sacroiliac Joint Fusion.
Topics:

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters